Access to patient RWD up for grabs

Posted 28 February 2024 PM

Not-for-profit Crohn's Colitis Cure has opened access to its extensive real-world patient data to assist pharmaceutical companies in regulatory approvals and funding decisions.

"The key to unlocking the potential for personalised, targeted and effective therapies is access to real-world IBD patient data and insights, which will help inform regulatory approvals and speed to access," CCCure CEO, Bill Petch, said.

To see the whole article, please login